PURPOSE. The retinal pigment epithelium (RPE) expresses aquaporin-1 (AQP1) and components of the natriuretic peptide signaling pathway. We hypothesized that stimulation of the natriuretic signaling pathway in RPE with atrial natriuretic peptide (ANP) and with membrane-permeable analogs of cGMP would induce a net apical-to-basal transport of fluid.
RESULTS.
Our results demonstrated a 40% increase in net apicalto-basal fluid transport by ANP (5 lM) that was inhibited completely by the ANP receptor antagonist anantin and a 60% increase in net apical-to-basal fluid transport in response to the extracellularly applied membrane-permeable cGMP analog pCPT-cGMP (50 lM), which was not affected by the protein kinase G inhibitor H-8. The aquaporin antagonist AqB013 (20 lM) inhibited the cGMP-stimulated RPE fluid flux.
CONCLUSIONS. The effect of cGMP is consistent with an enhancement of the net fluid flux in RPE mediated by AQP1 channels. Pharmacologic activation of cGMP signaling and concomitant stimulation of fluid uptake from the subretinal space could offer insights into a new approach to treating or reducing the risk of retinal detachment. (Invest Ophthalmol Vis Sci. 2012;53:2127-2132) DOI:10.1167/iovs. T he retina is the multilayered neural network in the eye that transforms light information into neural impulses, which travel through the optic nerve to the visual centers of the brain. The retinal pigment epithelium (RPE) is a protective barrier in the back of the eye that absorbs stray photons, provides trophic and metabolic support of sensory retinal cells, and is an essential component of the blood-retinal barrier. The atrial natriuretic peptide (ANP) receptor natively expressed in RPE and other tissues is a guanylate cyclase that increases intracellular cGMP in response to peptide binding. 1, 2 ANP is involved in the regulation of fluid movement in tissues including heart, kidney, and brain. [3] [4] [5] Evidence suggests local sources of ANP also are located within the eye. 2, 6 The water channel aquaporin-1 (AQP1) is expressed in RPE and a number of other fluid-transporting tissues. 7, 8 Changes in levels of expression and trafficking of aquaporin channel proteins in conditions of dehydration or edema have been demonstrated to be important for modulation of water transport capacity. 9, 10 The concept that AQP1 channels enable water flux out of the subretinal space was supported by work that showed a reduction of fluid transport in cultured RPE after treatment with AQP1-specific antisense RNA. 11 Investigation of detailed physiologic roles of aquaporins in dynamic regulation of fluid transport has been slowed by the lack of pharmacologic agents that directly block AQP channels. 12 The recent discovery of an effective pharmacologic inhibitor of AQP1 and AQP4 channels, AqB013, 13 has opened new opportunities to test for direct roles of water channels in physiologic conditions.
The potential translational relevance is in defining possible factors that contribute to subretinal edema formation and risk of retinal detachment. Impairing fluid clearance from retinal tissue promotes retinal edema formation.
14 A decrease in cGMP content has been linked with conditions of retinal detachment in animal models 15 and in clinical studies. 16 Data presented here show that ANP and cGMP stimulate apical-tobasal fluid movement in confluent monolayers of differentiated human retinal pigment epithelium in vitro and indicate that the cGMP-activated response is independent of protein kinase G (PKG). Effects of a pharmacologic AQP blocker, AqB013, indicate that water channel activity of AQP1 is necessary for the effect of cGMP on retinal fluid homeostasis. Characterizing the molecular mechanisms that control fluid transport across human RPE is important for understanding processes that contribute to normal RPE physiology and pathophysiology in conditions such as retinal detachment, which, if left untreated, ultimately results in blindness. 17 
MATERIALS AND METHODS

Human Retinal Pigment Epithelium Cell Culture Preparation
Retinal pigment epithelium from a human tissue donor was prepared using precisely optimized culture methods, reported previously to enable differentiation of properties comparable to those seen in vivo, including establishment of polarity, transepithelial electrical resistance, and pigmentation. 18 In brief, newly proliferated cells were collected every 3 to 4 days from primary tissue maintained in low calcium medium over a period of approximately 4 weeks and frozen in culture medium supplemented with serum and dimethyl sulfoxide (DMSO; 10% DMSO and 10% fetal bovine serum, v/v in Dulbecco's modified Eagle's medium). Cells were thawed, combined, plated at~300,000 cells per well on filters (12 mm Millicell HA; Millipore, Billerica, MA) coated with laminin (~1 to 2 lg; Sigma-Aldrich Cat#L2020) and cultured in a CO 2 -controlled 378C incubator for 8 to 10 weeks. Transepithelial resistances measured using a volt-ohm meter (World Precision Instruments, Sarasota, FL) were monitored to confirm integrity of the confluent monolayer at the start of the 2-day experiments. Filters with RPE-cultured cells had a mean net resistance of >500 Ohm cm 2 , calculated from the measured total resistance minus the average resistance of cell-free filters in media. Use of human tissue was done in accord with the Declaration of Helsinki ethical guidelines.
Measurement of Fluid Displacement Rates in RPE Cultures
The rates of net fluid transport by RPE cell layers at 378C in filter chambers were determined from the change in mass of the fluid present in the apical chamber, sampled at 2-hour intervals. Baseline fluid transport assays confirmed cell viability and set the control value of transport for paired comparisons done on the same day. The initial volume in the apical chamber, replaced at the start of each 2-hour treatment interval, was 150 lL isotonic (300 mOsM) saline with or without pharmacologic agents as specified. The basolateral chamber contained 1 mL of isotonic saline. Rates were calculated as volume per hour based on the mass of apical chamber fluid content converted to microliters and divided by 0.6 to account for the area of the Millicell filter, yielding units of lL/(h cm 2 ). Data are summarized as total transport rates or as net transport rates (treatment minus baseline), as indicated. Statistically significant differences in fluid transport rates between treatments and paired baseline control data were analyzed using ANOVA for multiple comparisons, and post hoc paired Student's t-test, with significance set at P < 0.05. 
Western Blot Analysis
Proteins collected from RPE culture lysates in Laemmli buffer 19 were run on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis gels (0.3 mA for 1 h), and transferred to nitrocellulose (100 mV for 90 minutes). Following transfer, nitrocellulose blots were incubated 1 h in blocking buffer TBS-T (100 mM Tris, 137 mM NaCl, 2.7 mM KCl, pH 7.4, with 2% Tween-20 and 5% nonfat dry milk), and then 16 hours at 48C in blocking buffer containing 300 ng/mL anti-AQP1 (affinity-purified polyclonal rabbit anti-AQP1 antibodies targeted against the carboxyl terminal domain of AQP1 as previously described. 20, 21 Blots were rinsed (4 times at 15 minutes each) in TBS-T, incubated 1 hour in blocking buffer with goat anti-rabbit IgG conjugated to horseradish peroxidase (Santa Cruz, CA) at a dilution of 1:5000, and rinsed again as before. Protein antibody complexes were visualized by chemiluminescence (HyGlo; Denville Scientific, Metuchen, NJ, #RPN2106 and RPN2135) recorded on x-ray film (Genesee, CA).
PKG Activity Assay
Confirmation that H-8 used in the RPE transport studies was effective in blocking PKG activity was assessed using a Cyclex cGMP-dependent protein kinase Assay Kit (MBL International, Woburn, MA, #CY-1161), as per the manufacturer's guidelines. Briefly, the purified catalytic domain of PKG was incubated with 125 lM ATP for 30 minutes in the presence or absence of H-8, and enzymatic activity was determined by phosphorylation of a peptide substrate using an anti-phospho-amino acid antibody provided with the kit. Colorimetric changes were measured with a Molecular Devices 96-well plate reader (450 nM).
Human AQP1 Channel Expression in Xenopus Oocytes
Unfertilized oocytes of Xenopus laevis were obtained by partial ovariectomy, treated with collagenase in nominally Ca 2+ -free saline, transferred to standard isotonic saline (ND96), and injected with cRNA transcribed in vitro from linearized human AQP1 cDNA, by methods described previously. 22, 23 Swelling rates were assessed by video microscopy in 50% hypotonic saline, with images captured at 2-second intervals for 40 seconds. Oocytes were immediately transferred to isotonic saline for 1.5 to 2 hours with AqB013 at 0, 20, or 50 lM and then subjected to a second swelling assay in 50% hypotonic saline.
Rates of swelling were determined from the slope of the linear fit of the relative area as a function of time in hypotonic saline. Animal use was in accord with the Association for Assessment and Accreditation of Laboratory Animal Care International guidelines, with protocols approved by the University of Adelaide Animal Ethics committee.
RESULTS
Validation of the Human Retinal Pigment Epithelial Culture Model
The pharmacologic dissection of RPE fluid transport was facilitated by the use of an in vitro model that retains distinctive in vivo features. Methods for establishing and maintaining human RPE cultures were optimized empirically 18 to achieve characteristic properties of RPE, including hexagonal cell morphology, high transepithelial resistance plus correct expression, and localization of marker proteins such as the Na + -K + -ATPase pump. 24 Cultured RPE cells generated pigment granules characteristic of the differentiated phenotype (Fig. 1a) . Expression of aquaporin-1 protein in cultured RPE 11 was confirmed by Western blot analysis of cell lysates of cultured RPE, probed with anti-AQP1 antibodies (Fig. 1b) . The signals in cultured RPE were comparable with those seen in bovine trabecular meshwork and mouse kidney, which served as positive controls. 25, 26 Variations in intensity of the heavier band are likely to reflect differences in glycosylation patterns across tissues and species.
Differences in baseline fluid transfer rates did not result from a passive leak across the barrier cell layer (Figs. 1c, 1d) . A plot of the transepithelial resistance against the baseline flux rate for the same culture showed no correlation within any of the control groups (isotonic saline with serum, with DMSO, and serum-free), in that none of the slopes of the linear regression fits were significantly different from zero. The mean transepithelial resistance values (-SEM, as X cm 2 ) were 591 -16 (n = 48) for isotonic saline with serum, 523 -12 (n = 18) for isotonic with 0.2% (v/v) DMSO, and 562 -16 (n = 41) for serum-free isotonic saline.
Stimulation of RPE Fluid Transfer by cGMP
Significant increases in the apical-to-basolateral fluid transfer rate in human RPE cultures were induced by endogenous and exogenous stimulation of cGMP signaling over a broad range of baseline transport rate values (Fig. 1d) , as seen in the data for total fluid flux rates at baseline (x-axis) plotted against the flux rate in the same filter culture after treatment with ANP or 8p-CPT-cGMP (y-axis). The dotted reference line shows unity, representing the expected position of data points if there were no difference between baseline and treated rates of fluid transfer. Most data points are above the reference line, illustrating the reproducible stimulatory effect of cGMP treatment across samples. ANP significantly increased the fluid transfer rate by 40% and 8pCPT-cGMP by 60% as compared with baseline control rates (Fig. 2a) . Statistically significant increases in fluid flux rates were observed for 5 lM ANP and for 50 lM 8p-CPT-cGMP, applied extracellularly. The mean total transport rate (-SEM) for ANP-treated cells was 7.5 -0.5 lL/h cm 2 (n = 11), and the paired baseline control was 5.4 -0.6 (n = 11). The mean total transport rate (-SEM) for cells exposed to 8p-CPT-cGMP was 11.1 -0.9 lL/h cm 2 (n = 10), and the paired baseline control was 7.0 -0.8 (n = 10). A consistent stimulation of total fluid transport rate also was seen with extracellular 20 mM 8Br-cGMP (Fig. 2b) . The mean stimulation by 8Br-cGMP was 86% over the baseline transport rates. The plot of control and corresponding experimental fluid shift values for each monolayer tested with 8-Br-cGMP demonstrates the consistency of this treatment across individual primary cultures (Fig. 2b) . The concentration of 20 mM of 8-Br-cGMP was comparable with that used in studies of perfused rabbit eye. 27 Given that the membrane is a barrier to drug delivery, the effective intracellular doses are expected to be lower. The apparent order of potency (8p-CPT-cGMP > 8Br-cGMP) observed here is consistent with known differences in membrane permeability. 28 The stimulatory effect of 8pCPT-cGMP on RPE fluid transport was dose dependent based on the average response at each dose (Fig. 3) , with a half-maximal activation dose (EC 50 ) at approximately 102 lM, applied extracellularly.
Pharmacologic Block of Human AQP1 Channels
The dose-dependent block of fluid flux by an aquaporin channel blocker, AqB013, in Xenopus oocytes expressing human AQP1 is illustrated in Figure 4 . Oocytes expressing human AQP1 channels showed approximately 70% inhibition of osmotic water permeability (monitored by cell swelling) after treatment with AqB013 at 20 lM and approximately 85% inhibition after treatment with 50 lM AqB013, as compared with AQP1-expressing oocytes not treated with the blocker. Control oocytes (not injected with AQP1 cRNA) showed no appreciable osmotic water permeability in identical swelling assays and no difference after treatment with 20 lM AqB013. 13 Data were standardized by dividing the second swelling rate (S2) by the first swelling rate (S1) measured for the same oocyte and expressed as a percentage (% S2/S1). This method allows each oocyte to serve as its own control, minimizing the effects of differences in AQP protein expression between oocytes.
Pharmacologic Analysis of the Stimulatory Effect of cGMP on RPE Fluid Transport
Anantin (50 lM), a selective antagonist of natriuretic peptide receptor guanylate cyclase activity, 29 opposed the stimulatory effect of 5 lM ANP on the net fluid transfer out of the apical chamber (Fig. 5) . These results indicated that ANP signaling acts through a receptor-mediated cGMP signaling pathway to increase apical fluid displacement in human RPE cultures. The AQP1 inhibitor, AqB013 (20 lM), blocked the stimulatory effect of the cGMP analog 8p-CPT-cGMP on net fluid transfer in RPE, suggesting that cGMP-induced fluid transport is dependent on the presence of functional AQP1 channels. The net fluid transport values described in Figure 5 are comparable with the total transport values minus baseline values shown in Figure 2 , showing consistency between experiments. The protein kinase inhibitor H-8 (100 lM) failed to block the stimulatory effect of 8p-CPT-cGMP on net fluid transfer, indicating that cGMP-induced fluid movement occurs independently of PKG and potentially protein kinase A (PKA) activity as well. Activity of the H-8 agent was confirmed separately in a standard assay of PKG enzymatic activity, in which PKG phosphorylation of a commercial peptide substrate was assessed using ATP and the purified catalytic domain of PKG, with and without H-8 present. Results of the assay showed that H-8 blocked PKG activity by 87%, based on the optical density values of 1.74 -0.20 (mean -SD, n = 3) for control and 0.23 -0.13 (paired; t-test, P < 0.05) with H-8 present. These data demonstrated that the observed lack of effect of H-8 on cGMP-stimulated fluid transport in RPE cultures did not result from a lack of potency of the H-8 compound.
DISCUSSION
Results presented here show that cGMP increases fluid displacement from the apical to the basolateral side of cultured human retinal pigment epithelium and that the stimulatory effect depends on the presence of functional AQP1 channels. Increased fluid transport triggered by endogenous atrial natriuretic peptide receptors was mimicked by the extracellular application of membrane-permeable analogs of cGMP. The response was not altered in the presence of H-8, an inhibitor of protein kinases including PKG, suggesting that cGMP is binding directly to target channels or transporters, rather than working indirectly through kinase-mediated phosphorylation. The effect of atrial natriuretic peptide was reversed by the selective receptor antagonist anantin. The stimulatory effect of the cGMP analog 8p-CPT-cGMP on net fluid transfer was reduced by the AQP antagonist AqB013.
Natriuretic peptide receptors have been detected in human retina and RPE.
1,2 ANP significantly increases intracellular cGMP levels in human RPE, whereas the nitric oxide donor Nanitroprusside (an activator of soluble guanylyl cyclase) is less effective. 30, 31 In the rabbit RPE in culture, the application of ANP increases chloride uptake, 32 an effect that is reduced by inhibition of PKG by KT5823. Recent investigation of interferon-gamma signaling via cyclic nucleotides cGMP and cAMP in human RPE demonstrated an increase in fluid transport that was reduced in the presence of either PKA inhibitor H-89 or inhibition of CFTR at the basal membrane. 33 We observed similar responses in human RPE upon treatment with ANP and cGMP, although in our study, the addition of H-8 (which blocks PKG and PKA 34 ) did not affect cGMP-stimulated fluid transport. The combined data indicate that cyclic nucleotides in the RPE can regulate fluid flux by altering the activity of multiple pathways via kinases as well as second messengers, modulating an array of channels and transporters, with experimental differences potentially indicative of the effects of tissue preparation, age, or environmental factors.
Potassium and sodium channels serve as ion conduction pathways for baseline RPE fluid absorption. [35] [36] [37] An important contributor to the net apical-to-basolateral flow of salt and water across the RPE is the Na 38 ,39 a primary route for chloride uptake that contributes to the transepithelial driving force for water. 40 The Na + -K + -2Cl -cotransporter appears to be regulated mainly by PKA. 41 Inhibition of PKG with KT5823 did not reduce Na
cotransporter activity in ciliary epithelial tissues following stimulation with isoproterenol. 42 Conversely, activation of PKG by cGMP inhibited the Na + -K + -2Cl -cotransporter in rat atrial myocytes. 43 The effects of cGMP in our study, seen as a stimulation of net fluid transport, would not be consistent with a downregulation of cotransporter activity, suggesting additional targets are involved in the stimulatory response.
The AQP blocker AqB013 13 is effective at inhibiting aquaporin-mediated osmotic water fluxes in the Xenopus oocyte expression system; 70% AQP1 block was seen at 20 lM AqB013 (Fig. 4) . The stimulation of fluid transport by 8p-CPTcGMP was significantly reduced by the concomitant block of water transport in AQP1 channels with AqB013, indicating an essential role for AQP1 in the enhanced fluid transport response to cGMP. The current data are in agreement with previous studies demonstrating the importance of AQP1 in RPE fluid transport as determined by siRNA treatment and adds a more immediate potential mode of translational therapy to the current strategies for treating diseases associated with retinal detachment.
The results indicate that AQP1 channels become ratelimiting factors in the regulation of transepithelial fluid transport if water channel activity is substantially compromised, suggesting other transporter and leak pathways for water flow are insufficient for maximally efficient fluid handling in RPE. The role of the water channels in the cGMP response is expected to be primarily an osmotically-driven process that is occurring in parallel to cGMP-regulated salt transport through pumps, transporters, and ion channels. However, the results also are consistent with an additional role for cGMP signaling pathways, including the direct gating of AQP1 channels. 22, 23 In the choroid plexus, ANP slows fluid secretion and decreases the rate of production of cerebral spinal fluid. 5 .This downregulation of choroid plexus fluid transport by ANP is influenced by cGMP-mediated activation of a nonselective cation conductance associated with AQP1 channels. 41, 44, 45 If cation channel activity were confirmed for AQP1 channels in the RPE, the equivalent mechanism would be consistent with an observed promotion of fluid absorption and enhanced clearance of fluid from the subretinal space in response to cGMP. 8 The attachment of the retina to the posterior eye depends on extracellular interactions between retina and RPE, 46 pressure differences between the vitreous and the choroid regions, 47 and transport processes that reduce the fluid volume of the subretinal space. [48] [49] [50] Regulation of subretinal volume is thought to be essential in preventing retinal edema formation and rhegmatogenous retinal detachment. 51 Low levels of cGMP have been correlated with cases of retinal detachment, 15, 16 and thus, decreased cGMP signaling could contribute to the risk of retinal detachment. Current therapies use vitreal pressure to tamponade the retina and laser, thermal, and cryogenic methods for physically reattaching the retina to the RPE. 52 Pharmacologic approaches to reducing edema, such as targeting cGMP levels in RPE, could increase the success of retinal reattachment surgeries and reduce the risk of retinal detachment as an adverse consequence of traumatic injury or postcataract surgery. Cataract is the leading cause of blindness in the world; the risk of retinal detachment increases more than fivefold in patients within 10 years after cataract surgery. 53 With an aging population, the discovery of pharmacologic tools for maintaining retinal health and visual function is a compelling goal.
